Welcome to our dedicated page for Amazon Com SEC filings (Ticker: AMZN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding AWS operating margins or spotting executive stock sales inside Amazon鈥檚 sprawling SEC documents can feel like searching for a package without tracking. Buried in a 300-page annual report, the cloud unit鈥檚 profitability and Prime membership growth appear only briefly, while Form 4 insider trades may post after market close. If you have ever Googled 鈥淎mazon insider trading Form 4 transactions鈥� or 鈥渉ow to read Amazon鈥檚 annual report 10-K simplified,鈥� you know the challenge.
Stock Titan eliminates that roadblock. Our AI engine ingests every Amazon quarterly earnings report 10-Q filing, 8-K material events, and proxy statement executive compensation disclosure the moment EDGAR releases them. It then produces plain-English highlights so you can grasp what matters鈥攚ithout wading through legal language. Key features include:
- AG真人官方-time Amazon Form 4 insider transactions alerts
- AI summaries that turn dense footnotes into clear takeaways
- Segment-level dashboards for Retail, AWS, and Advertising trends
- Searchable archive covering every filing type, from S-8s to 424Bs
Investors use these insights to monitor fulfillment-center capital spending, compare AWS margin expansion quarter-over-quarter, and flag governance issues before proxy voting season. Understanding Amazon SEC documents with AI means you spend minutes鈥攏ot hours鈥攐n due diligence. From Amazon 8-K material events explained to Amazon quarterly earnings report 10-Q filing details, our coverage stays current so that your decisions stay informed.
Everi Holdings Inc. (EVRI) filed Post-Effective Amendment No. 1 to twelve prior Form S-8 registration statements covering an aggregate of approximately 48.6 million shares of common stock reserved for various equity compensation plans dating back to 2006. The amendment formally deregisters all unsold shares under those statements.
The action follows the 1 July 2025 closing of a multi-party transaction in which funds managed by affiliates of Apollo Global Management (through Voyager Parent, LLC) simultaneously acquired Everi and International Game Technology PLC鈥檚 Gaming & Digital business:
- IGT transferred its Gaming & Digital assets to Ignite Rotate LLC ("Spinco") and related liabilities (the 鈥淪eparation鈥�).
- Buyer purchased all Spinco units and IGT Canada Solutions ULC shares.
- Voyager Merger Sub, Inc. merged with and into Everi, making Everi a wholly owned subsidiary of Buyer (the 鈥淢erger鈥�).
Because Everi鈥檚 common stock will be delisted and deregistered under Section 12(b) of the Exchange Act, the company is terminating all outstanding securities offerings. Upon effectiveness of this filing, no shares remain registered for sale under the referenced S-8 statements.
Vir Biotechnology, Inc. (VIR) 鈥� Form 144 filing overview
The filing discloses a proposed secondary sale of 66,000 common shares of Vir Biotechnology under Rule 144. The shares were originally acquired on 17 Jan 2017 as pre-IPO stock and are held in the name of an undisclosed insider (the form does not specify the individual or relationship to the issuer). Morgan Stanley Smith Barney LLC, Executive Financial Services, is listed as the broker for the transaction.
- Shares to be sold: 66,000
- Aggregate market value: US $332,640
- Planned sale date: 1 Jul 2025
- Total VIR shares outstanding: 138,238,003
- Percent of shares outstanding: ~0.05 % (66,000 ÷ 138,238,003)
- Exchange: NASDAQ
No sales by the filer have occurred within the prior three months, and the securities were not purchased with non-cash consideration according to the disclosure. The seller certifies awareness of no undisclosed material adverse information and acknowledges potential criminal liability for misstatements.
Given the modest size relative to VIR鈥檚 float and the absence of multiple tranches or recent insider selling, this notice is unlikely to have a material impact on the company鈥檚 capital structure or market dynamics. However, investors may monitor for additional filings that could signal a broader disposition program.
Amazon.com, Inc. (AMZN) has filed a Form 144 notice covering a large insider transaction by founder Jeffrey P. Bezos. The filing states that Bezos, identified as both Director and Officer, intends to sell 25,000,000 common shares through Morgan Stanley Smith Barney LLC on or about 26 June 2025. The shares carry an aggregate market value of US$5.428 billion. Amazon reports 10,616,352,407 shares outstanding, so the proposed sale represents roughly 0.24 % of shares in issue. Trading will occur on the NASDAQ.
The shares were originally acquired on 5 July 1994 as founder鈥檚 stock. Bezos adopted a Rule 10b5-1 trading plan on 4 March 2025, signalling that the sale schedule was predetermined and intended to comply with insider-trading safe-harbour rules. In the representation section, Bezos affirms that he possesses no undisclosed material adverse information about Amazon.
Recent share activity: the filing notes that on 13 May, 14 May and 3 June 2025, Bezos donated a combined 633,812 shares to non-profit organisations, which may have subsequently sold those shares. No other sales by the reporting person were recorded in the past three months.
While sizeable in dollar terms, the planned disposition is limited relative to Amazon鈥檚 float and is being executed under a disclosed trading plan, which may mitigate market-impact concerns. Nevertheless, the transaction removes a significant block of founder-held shares from potential long-term insider ownership.